This commentary addresses concerns about defamation risks in CC BY licensing and attribution practices.
The problem with non-lawyers, like me, speculating on legal matters is that there's a risk of scaremongering or just plain inaccuracy. Not that this really ever stops the practice -- and it won't here. In any case, I wanted to re-state [the question that I raised yesterday](/2019/01/23/additional-points-in-my-plan-s-response/) and that I'd like addressed about CC BY and defamatory attribution.
No takes yet. Share an insight, caveat, or question.
Martin Paul Eve (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: